GUIDELINE TITLE
Diagnosis and initial treatment of ischemic stroke.
BIBLIOGRAPHIC SOURCE(S)
Institute for Clinical Systems Improvement (ICSI). Diagnosis and initial treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2009 Jun. 63 p. [168 references]GUIDELINE STATUS
This is the current release of the guideline.
This guideline updates a previous version: Institute for Clinical Systems Improvement (ICSI). Diagnosis and treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2008 Jun. 57 p. [146 references]
** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERTNote from the National Guideline Clearinghouse: This guideline references a drug(s)/intervention(s) for which important revised regulatory and/or warning information has been released.
November 17, 2009 - Plavix (clopidogrel): The U.S. Food and Drug Administration (FDA) notified healthcare professionals of new safety information concerning an interaction between clopidogrel (Plavix) and omeprazole (Prilosec/Prilosec OTC) used to reduce stomach acid. New data show that when clopidogrel and omeprazole are taken together, the effectiveness of clopidogrel is reduced.
abrir aquí para acceder al documento NGC AHRQ completo:
Diagnosis and initial treatment of ischemic stroke.
No hay comentarios:
Publicar un comentario